Clinical Trial Update: PD-1 Inhibitors With or Without Radiation in Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PD-1 inhibitors with or without radiotherapy in patients with advanced melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Fudan University | Conditions: the Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced Melanoma | Phase 2 | Status: UNKNOWN